Ki-67 Image Cytometric Quantitation and Oncotype Dx Recurrence Score in Estrogen Receptor-Positive Breast Cancer

被引：0
|
作者：
Williams, D. J. [1 ]
Cohen, C. [1 ]
Darrow, M. [1 ]
Page, A. J. [1 ]
Chastain, B. [1 ]
Adams, A. [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
342
引用
收藏
页码：78A / 78A
页数：1
相关论文
共 50 条
  • [41] Comparison of Magee and Oncotype DX Recurrence Scores in estrogen receptor positive breast cancers
    Walts, Ann E.
    Mirocha, James M.
    Bose, Shikha
    [J]. BREAST JOURNAL, 2018, 24 (06): : 951 - 956
  • [42] Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer
    Kyoko Yorozuya
    Toru Takeuchi
    Miwa Yoshida
    Yukako Mouri
    Junko Kousaka
    Kimihito Fujii
    Shogo Nakano
    Takashi Fukutomi
    Kazuo Hara
    Shu Ichihara
    Yingsong Lin
    Shogo Kikuchi
    [J]. Journal of Cancer Research and Clinical Oncology, 2010, 136 : 939 - 944
  • [43] Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer
    Yorozuya, Kyoko
    Takeuchi, Toru
    Yoshida, Miwa
    Mouri, Yukako
    Kousaka, Junko
    Fujii, Kimihito
    Nakano, Shogo
    Fukutomi, Takashi
    Hara, Kazuo
    Ichihara, Shu
    Lin, Yingsong
    Kikuchi, Shogo
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (06) : 939 - 944
  • [44] Oncotype DX score in hormone receptor-positive/HER2-positive breast cancer: A SEER analysis.
    Qasrawi, Ayman
    Myint, Zin
    Alnimer, Yanal Mufeed
    Romond, Edward H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Can high Ki67 predict distant recurrence in early stage breast cancer with low oncotype Dx score?
    Fallah, P.
    Mulla, N.
    Rose, A. A. N.
    Panasci, L.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S425 - S426
  • [46] Validation of automated Ki67 analysis to predict Oncotype DX recurrence score in early-stage breast cancer
    Chan, Angela M. Y.
    Abedin, Tasnima
    Thakur, Satbir
    Li, HaoCheng
    Konno, Mie
    Enwere, Emeka
    Lupichuk, Sasha
    Nixon, Nancy
    Morris, Donald
    Yang, Hua
    Neri, Paola
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [47] Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer
    Patel, Rima
    Hovstadius, Malin
    Kier, Melanie W.
    Moshier, Erin L.
    Zimmerman, Brittney S.
    Cascetta, Krystal
    Jaffer, Shabnam
    Sparano, Joseph A.
    Tiersten, Amy
    [J]. CANCER, 2022, 128 (20) : 3602 - 3609
  • [48] Clinical outcomes and Oncotype DX Breast Recurrence Score (R) in early-stage BRCA-associated hormone receptor-positive breast cancer
    Layman, Rachel M.
    Lin, Heather
    Barrera, Angelica M. Gutierrez
    Karuturi, Meghan S.
    Yam, Clinton
    Arun, Banu K.
    [J]. CANCER MEDICINE, 2022, 11 (06): : 1474 - 1483
  • [49] CORRELATION OF KI-67 PROLIFERATIVE INDEX WITH ONCOTYPE DX RECURRENCE SCORE IN HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE EARLY BREAST CANCER WITH LOW-BURDEN AXILLARY NODAL DISEASE - A REVIEW OF 137 CASES
    Al-Zawi, Abdalla Saad Abdalla
    Anichkina, Kristina Arsenievna
    Elamass, Mohamed
    Aladili, Zina
    [J]. POLISH JOURNAL OF PATHOLOGY, 2024, 75 (01) : 8 - 18
  • [50] Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor-Positive Breast Cancer
    Penault-Llorca, Frederique
    Andre, Fabrice
    Sagan, Christine
    Lacroix-Triki, Magali
    Denoux, Yves
    Verriele, Veronique
    Jacquemier, Jocelyne
    Baranzelli, Marie Christine
    Bibeau, Frederic
    Antoine, Martine
    Lagarde, Nicole
    Martin, Anne-Laure
    Asselain, Bernard
    Roche, Henri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2809 - 2815
12345